Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.

Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery

Inspired by her mother, Vicky Qi leads drug discovery teams.

When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.

NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics

Novartis CEO Vas Narasimhan answers questions about COVID-19.